These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14559143)

  • 1. Effects of a beta blocker and spironolactone on plasma homocysteine levels.
    Korkmaz ME; Atar I; Tayfun E; Yildirir A; Ulucam M; Ozin B; Muderrisoglu H; Turan M
    Int J Cardiol; 2003 Oct; 91(2-3):259-60. PubMed ID: 14559143
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a beta-blocker and spironolactone on plasma homocysteine levels.
    Korkmaz ME; Atar I; Tayfun E; Yildirir A; Ulucam M; Ozin B; Muderrisoglu H; Turan M
    Int J Cardiol; 2003 Mar; 88(1):119-20. PubMed ID: 12659999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta blockers in hypertension treatment Will stepping back come soon?].
    Sawicki PT; Anlauf M; Haller H
    MMW Fortschr Med; 2007 Mar; 149(11):6. PubMed ID: 20104695
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta blocker effects on plasma homocysteine levels in patients with hypertension.
    Atar I; Korkmaz ME; Demircan S; Atar IA; Bozbaş H; Aydinalp A; Ozin B; Yildirir A; Müderrisoğlu H
    Atherosclerosis; 2005 Aug; 181(2):399-402. PubMed ID: 16039296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension.
    Oxlund CS; Cangemi C; Henriksen JE; Jacobsen IA; Gram J; Schousboe K; Tarnow L; Argraves WS; Rasmussen LM
    J Hum Hypertens; 2015 Jan; 29(1):28-32. PubMed ID: 24739800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for the medical management of arterial hypertension (author's transl)].
    Hall D; Goedel-Meinen L; Rudolph W
    Herz; 1978 Oct; 3(5):289-99. PubMed ID: 31327
    [No Abstract]   [Full Text] [Related]  

  • 7. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of distensibility of the aorta in elderly patients during long-term therapy with various classes of hypotensive drugs (magnetic resonance tomography data)].
    Martynov AI; Ternovoĭ SK; Ostroumova OD; Sinitsyn VE; Pustovitova TS; Gedgafova SIu; Sharkova NE
    Kardiologiia; 2002; 42(5):19-22. PubMed ID: 12494142
    [No Abstract]   [Full Text] [Related]  

  • 9. A new look at the treatment of severe hypertension.
    Kincaid-Smith P; Fang P; Laver MC
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():75s-87. PubMed ID: 4150273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension.
    Collste P; Danielsson M; Elmfeldt D; Feleke E; Gelin A; Hedner T; Rydén L
    Drugs; 1985; 29 Suppl 2():124-30. PubMed ID: 2859184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC; Ortíz Feijoo J; Otero Cagide F
    Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive agents used as first line agents: beta-blockers under pressure].
    Burnier M; Pechère A; Waeber B
    Rev Med Suisse; 2006 Sep; 2(78):2019-20. PubMed ID: 17019836
    [No Abstract]   [Full Text] [Related]  

  • 15. [Assessment of the antihypertensive therapy with 24 ambulatory monitoring of blood pressure].
    Sugai J; Mikawa T
    Nihon Rinsho; 1992 May; 50 Suppl():39-45. PubMed ID: 1355136
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological basis for combination therapy of hypertension.
    Dolley CT
    Annu Rev Pharmacol Toxicol; 1977; 17():311-23. PubMed ID: 17355
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential therapeutic principles in the drug therapy of high blood pressure].
    Rahn KH
    Internist (Berl); 1974 Mar; 15(3):157-64. PubMed ID: 4151964
    [No Abstract]   [Full Text] [Related]  

  • 18. Should diuretics be combined with calcium antagonists?
    Lazar AI
    J Assoc Physicians India; 1996 Jan; 44(1):71-2. PubMed ID: 8773109
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.
    Cavallari LH; Momary KM; Groo VL; Viana MA; Camp JR; Stamos TD
    Pharmacotherapy; 2007 Jun; 27(6):801-12. PubMed ID: 17542763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.